Programme
Thursday 20 August
11.00–11.45 Registration and lunch
11.45–12.15 Opening of the 20th Annual FinPharmaNet Meeting
11.45–11.50 Opening remarks, Prof. Anu Kauppinen, UEF
11.50–12.15 A historical overview of FinPharmaNet, Prof. Paavo Honkakoski, UEF
12.15–13.15 Session I: Drug Discovery and Molecular Mechanisms
Chair: Postdoctoral Researcher Maria Hytti, UEF
12.15–12.45 Keynote: Director for Target Science Julia Lindqvist, Finnish Drug Discovery Center
Selecting the Right Target for the Right Patient: Foundations for Successful Drug Discovery
12.45–13.00 Academy Research Fellow Tatu Pantsar, UEF
Small GTPases: Challenging But Not Impossible Drug Targets
13.00–13.15 Associate Prof. Kristiina Huttunen, UEF
From Yoda1 to Jedi: Translating Piezo1 Agonists from Pharmacokinetics to Rational Ligand Optimization
13.15–13.30 Break
13.30–14.30 Session I continues
13.30–13.40 Madushani Bandara, UEF
Development of stereoselective synthesis of L-amino acid-based boron delivery agents for glioma-targeted boron neutron capture therapy (BNCT)
13.40–13.50 Aino Majanen, UH
pH-Dependent phase behavior of ibuprofen-copovidone based amorphous solid dispersions using in situ stimulated raman scattering (SRS) microscopy
13.50–14.00 Shujun Liang, ÅA
Granular hydrogel of photocurable cellulose nanofibers in service of 3D culture
14.00–14.10 Pekka Vanhanen, UEF
Effective process for screening melanin binding affinity of small molecule drugs and new drug candidates
14.10–14.20 Julius Viita, UEF
Novel melanin-binding carbonic anhydrase inhibitors for the treatment of glaucoma
14.20–14.30 Karla Saukkonen, UTU, ÅA
Development of an enzyme inhibition assay to evaluate drug-induced 7-dehydrocholesterol reductase (DHCR7) inhibition
14.30–14.45 Break
14.45–16.15 Session II: Innovative Formulation and Drug Delivery Technologies
Chair: Prof. Heidi Kidron, UH, UEF
14.45–15.15 Keynote: Prof. Hongbo Zhang, ÅA
Innovative Drug Delivery Technologies
15.15–15.30 Prof. Ossi Korhonen, UEF
Fixed-dose triple combination dispersible tablets for paediatric HIV — continuous direct compression vs. batch manufacturing
15.30–15.45 Head of Research Xiaoju Wang, ÅA
Sustainable biomass-derived lignin nanomaterials for antimicrobial applications
15.45–15.55 Rabia Gulshan, ÅA
Nanomaterial- and technology-driven approaches for combating antimicrobial resistance
15.55–16.05 Sachin Gautam, UH
Poly(jasmine lactone)-based micellar nanocarriers for improving tetracycline activity against resistant Escherichia coli
16.05–16.15 Roya Khoshtinatnikkhoy, UH
Antibiotic-coated urinary catheters for prevention of catheter-associated urinary tract infections: Comparing dipping and impregnation coating strategies
16.15–16.45 Coffee break
16.45–18.00 Session II continues
16.45–16.55 Oliver Koivisto, ÅA
Metal-organic framework nanoparticles as delivery vehicles for biological cargoes: From mitochondria to CRISPR/Cas9 plasmids
16.55–17.05 Zonghong Lu, ÅA
Lignin nanoparticles as sustainable platforms for drug delivery applications
17.05–17.15 Mengxue Lu, UH
Modulating the nano-bio interface of lignin nanoparticles through chitosan coating: Effects on cellular uptake, immunostimulation, and colloidal stability in biological media
17.15–17.25 Mahdieh Mozaffari Majd, ÅA
Influence of polymer backbone functionality and formulation method on solubilization and cellular uptake of nanoemulsions
17.25–17.30 Short break
17.30–17.40 Deependra Yadav, ÅA
NAP4DIVE: Non-animal platform for nanoparticle-based delivery across the blood-brain barrier interface with vehicle evolution
17.40–17.50 Erika Pennanen, UEF
Lipidomic and metabolic characterization of ocular retinoblastoma model and investigation of tumor targeting properties of PL3 peptide using LC-MS and MALDI-MSI
17.50–18.00 Ziyan Wang, UH
Engineering Liquid–Liquid Phase Separation nano condensates for Intracellular mRNA Delivery
18.00–18.30 Break
18.30–20.00 Dinner
20.00–23.00 Social program
Stand-up comedy performance by Fathi Ahmed, followed by an evening with DJ Ismo.
Karaoke bar Club R will be open until 01.00.
Friday 21 August
9.00–10.30 Session III: Clinical Applications and Personalized Therapies
Chair: Academy research fellow Tatu Lajunen, UEF
9.00–9.30 Keynote: Prof. Mikko Niemi, UH
Implementing Personalized Therapies in Healthcare: Pharmacogenomics in Practice
9.30–9.45 Postdoctoral researcher Maha Naser, UH
From Dairy DRAIN TO DRUG DELIVERY: Side-Stream Lactose in Semi-Solid Extrusion 3D Printing of Orodispersible Films and Multilayer Tablets
9.45–10.00 Senior Researcher Miia Tiihonen, UEF
Prediction and prevention of drug adverse effects: focus on anticoagulation therapy
10.00–10.10 Mahsa Bahman, ÅA
Semi-solid extruded tablets for personalized pediatric use: Development, quality control and in-vitro assessment of enteral tube administration
10.10–10.20 David Ekwe, UTU
6-[18F]Fluoronicotinic Acid PET Visualizes Intracranial Human Glioblastoma Xenografts that are [18F]FET PET Negative
10.20–10.30 Greta Välijärvi, UEF
Accumulation of fluorescent polystyrene particles in perfused human placenta
10.30–10.45 Break
10.45–11.45 Session III continues
10.45–10.55 Maritta Keurulainen, UH
Broccoli extract as a potential virulence inhibitor in uropathogenic Escherichia coli
10.55–11.05 Marina Castro Guerrero, UH
Comparative evaluation of cardiomyocyte spheroid formation and maturation under microfluidic and static 3d culture conditions
11.05–11.15 Khalfa Benadouda, UH
Synthetic HDL-based therapy for selective modulation of cholesterol efflux in atheroma macrophages
11.15–11.25 Hamed Maljaei, UEF
Organic Anion Transporting Polypeptide (OATP) -utilizing prodrugs to improve intra-brain drug delivery for neuroprotective agent
11.25–11.35 Jonne Kunnas, ÅA
Biodistribution of [68Ga]Ga-labeled nanoerythrosomes
11.35–11.45 Emel Bakay, ÅA
Proof-of-concept study of brain metastasis PET imaging with 6-[18F]fluoronicotinic acid
11.45–12.45 Lunch + FinPharmaNet representatives meeting
12.45–14.10 Session IV: Optimizing Medicine Use and Future Directions
Chair: Prof. Katri Hämeen-Anttila
12.45–12.50 Opening the session, Prof. Katri Hämeen-Anttila, chair
12.50–13.10 Keynote: Prof. Pauline Norris, University of Otago, New Zealand
Optimizing access to medicines
13.10–13.30 Assistant Prof. Katri Aaltonen, UH
Optimizing medicine use on a population level
13.30–13.50 Prof. Katri Hämeen-Anttila, UEF
Future role of community pharmacies in optimizing medication use
13.50–14.10 Associate Prof. Anna-Riia Holmström, UH
Optimizing medication use in high-risk patients and care environments
14.10–14.30 Group photo + break
14.30–15.15 Session IV continues
14.30–14.40 Anni Kokolahti, UEF
Sensitivity of register-based quality indicators to changes in indicator definition: Lipid-lowering medication use in people with type 2 diabetes
14.40–14.50 Marianne Kouhia, UEF
Counselling roles regarding insulin treatment and automatic substitution of insulins: The perspectives of patients and healthcare professionals
14.50–15.00 Leena Reinikainen, UEF, FIMEA
Accessibility of expensive medicines: a national register study of retail distribution in Finland in the 2000s
15.00–15.10 Agnese Rönngård-Jalkanen, UEF
Experienced problems in pharmacotherapy monitoring and factors associated with them: A nationwide survey of medicine users
15.10–15.15 End of the session
15.15–15.45 Awards and closing of the meeting
15.45 Coffee and departure
🧡 Session I: Drug Discovery and Molecular Mechanisms (orange)
💛Session II: Innovative Formulation and Drug Delivery Technologies (yellow)
💚Session III: Clinical Applications and Personalized Therapies (green)
💜Session IV: Optimizing Medicine Use and Future Directions (purple)